Assisted Reproductive Technology Market Size To Attain USD 66.77 Bn By 2032

The global assisted reproductive technology market size was exhibited at USD 26.34 billion in 2022 and it is projected to attain around USD 66.77 billion by 2032, poised to grow at a CAGR of 9.8% between 2023 and 2032.

Assisted Reproductive Technology Market Size and Growth Rate From 2023 To 2032

The wide acceptance of the advance developed technology with new fertilization techniques introduced with increased efficiency of the treatment and enhance the rate of fertility among the women helped to grow the market of assisted reproductive technology. The increasing prevalence of infertility among women due to changing dietary intake, changing sedentary lifestyles, enhance ovulation disorders among women, and increasing obesity led to infertility. Which rise the demand for assisted reproductive technology with increasing the fertility rate. Covid -19 with a negative impact on the market due to reduced patients visiting the hospital and a halt in the market of assisted reproductive technology. The post-pandemic situation with enhanced market rate due to increased infertility and demands for advanced developed technologies helps to drive the market of assisted reproductive technology during the forecast period with increasing CAGR.

Report Highlights:

Assisted reproductive technology on the basis of the product involves the accessory and disposable segment account for the largest market growth with increasing demands from the market with enhanced market growth with increasing CAGR rate during the forecast period. With the increasing prevalence of infertility with increased demands for increasing the growth of developed technologies in assisted reproductive technology. Reagents & media with enhance market growth with increasing procedures involved such as embryo transfer due to the increasing rate of fertility. Drives to grow the market rate. Assisted reproductive technology based on technology. In Vitro Fertilization with enhanced demands from the market with an increasing rate of fertility is expected to rise the market growth with new advance developed technologies. 

Artificial insemination also with significant growth in the market due to increasing demands from the customer and enhance investment with constant research and development with increasing funds help to drive the market growth. Assisted reproductive technology on the basis of end-user, a Fertility clinic with the highest market share with increasing rates of infertility due to various reasons and increased patients visiting the clinic with increasing rate of fertility. Assisted reproductive technology on the basis of geography Asia Pacific region accounts for the largest growth with developed technologies in the regions with increasing infrastructure and enhance investment from the market helping to grow the market of assisted reproductive technology. Europe with the second highest market to grow with increasing demands from the market. North America and Middle East & Africa also with the increasing growth of assisted reproductive technology.

Assisted Reproductive Technology Market Report Scope:

Report Coverage Details
Market Revenue in 2023 USD 28.79 Billion
Projected Forecast Revenue in 2032 USD 66.77 Billion
Growth Rate from 2023 to 2032 CAGR of 9.8%
Largest Market Europe
Base Year 2022
Forecast Period 2023 To 2032
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa


Regional Snapshots:

The geographical sector of Asia Pacific regions accounts for the largest market growth in assisted reproductive technology with an increase in research and development with innovation involved for enhancing the fertility rate help to grow the market rate due to the increasing prevalence of infertility due to various problems such as ovulation disorder, changing lifestyle, sedentary lifestyle, dietary intake, growing obesity are the reasons which enhance the rate of infertility and increasing demands from the medical sector. The government provides funds for increasing the research and infrastructure development in the medical with developed technologies to help to grow the market rate. The key market players are the major role players which introduced new advanced technologies in assisted reproductive technology with wide acceptance with increasing fertility rate. Europe also with significant growth in assisted reproductive technology with new introductions and enhanced demands helps to rise the market rate. North America, the Middle East & Africa also contribute to developing the market growth.

Market Dynamics:

Drivers:

The new technologies with increased efficiency and efficacy of infertility treatment introduced by the key market players involved in assisted reproductive technology with continuous research and development of the new technologies with increasing investment help to grow the market rate. The rising prevalence of infertility among women due to various reasons such as increasing obesity, changing sedentary lifestyle, change in diet, and lack of exercise led to an increasing rate of infertility. Which accelerates the market of assisted reproductive technology with rising demands for the treatment. The availability of various options for treating infertility with increasing facilities and a growing rate of fertility. Which drives the market to a great height.

Restraints:

A major factor that may hinder the market of assisted reproductive technology due to numerous options available for treating infertility disorders. Variable policies introduced by the government reduced the rate of the market by decreasing the market value of assisted reproductive technology. Lack of awareness in underdeveloped regions among the people about increasing advanced technology developed in assisted reproductive technology with increasing fertility may decline the market of assisted reproductive technology during the forecast period and reduce the growth rate.

Opportunities:

Increased backup from the government with the introduction of the policies such as reimbursement and enhance investment from the government for increasing the research in assisted reproductive technology help to grow the market with enhanced rates and reduced demands. The emergence of underdeveloped regions with the introduction of new technologies in the market helped to grow the market with the increased number of facilities and improving infrastructure has driven the market of assisted reproductive technology with increasing demands from the medical sector. The key market players involved in assisted reproductive technology with the launch of new technology and increasing research and development help to grow the market with increasing investment from the players for developing new technologies and expansion of the market to a larger extent.

Challenges:

The enhanced cost of the newly developed technologies in assisted reproductive technology is due to increased efficiency. Which led to increasing costs of the treatment and may decline the market growth with reduced demands. Which in turn can challenge the market to enhance growth in the future. Increased technologies and techniques in performing the procedure with upgraded knowledge to carry out the procedure. Lack of skill among the people may decline the market growth rate with the reduced rate of performing the procedure and reduced rate of fertility may challenge the market growth of assisted reproductive technology during the forecast period. The increasing number of treatments for increasing the fertility rate reduced demands from the customer and decline the market of assisted reproductive technology.

Recent Developments:

  • Collaboration of Cooper Surgical and Virtus Health with improving technologies for growing the fertility rate with an increase in research and development and enhanced treatment for increasing the rate of fertility in the year 2021.
  • Development of GYNEMED GM501 from Hamilton Thorne Ltd in the year 2021. Techniques developed for washing and handling the oocytes and embryos by humans and clearance from the United States and Europe.

Major Key Players:

  • Vitrolife AB
  • Thermo Fisher Scientific, Inc
  • The Cooper Companies, Inc (Cooper Surgical Inc.)
  • Progyny Inc.
  • Oxford Gene Technology
  • Millendo Therapeutics, Inc
  • Merck KGaA (EMD Serono, Inc)
  • Genera Biomedx
  • Fujifilm Holdings Corporation (Irvine Scientific Sales Company)
  • Cook Medical Inc
  • Ferring B.V.
  • Bloom IVF Centre
  • European Sperm Bank
  • Microm U.K. Ltd
  • Cosmos Biomedical Ltd
  • Cryolab Ltd

Market Segmentation:

By Product

  • Instrument
    • Laser systems
    • Micromanipulator
    • Cabinet
    • Ovum aspiration pump
    • Imaging systems
    • Incubator
    • Cryosystem
    • Sperm separation system
    • Others
  • Accessory & Disposable 
  • Reagents & media
    • Embryo culture media
    • Ovum processing media
    • Semen processing media
    • Cryopreservation media

By Technology

  • In-Vitro Fertilization (IVF)
    • Fresh Donor
    • Frozen Donor
    • Fresh Non-Donor
    • Frozen Non-Donor
  • Artificial Insemination
    • Intrauterine Insemination
    • Intracervical Insemination
    • Intravaginal Insemination
    • Intratubal Insemination

By Diagnosis

  • Ovulation Testing
  • Hysterosalpingography

By End-User 

  • Ambulatory surgical centers
  • Hospitals
  • Clinics
  • Diagnostic centers
  • Gynecology Centers
  • Feminist Health Centers
  • IVF Centers

Buy this Research Report@ https://www.precedenceresearch.com/checkout/2329

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333